Acutaas Chemicals Ltd Share Price – NSE /  BSE

Pharmaceuticals, Small Cap

Revenue from operations jumped 37.13% year on year to Rs 308.48 crore during the quarter ended 31st March 2025.

Profit before tax (PBT) soared 122.66% to Rs 82.83 crore in Q4 FY25 as compared with Rs 37.20 crore in Q4 FY24.

EBITDA stood at Rs 85 crore, registering the growth of 96.8% as compared with Rs 432 crore in Q4 FY24. EBITDA margin was at 27.5% in Q4 FY25 as against 19.2% in Q4 FY24.

In Q4 FY25, export stood at 74% and domestic business was at 26%.

Naresh Patel, executive chairman & managing director, Ami Organics, said, ?I am delighted to share that FY25 was a transformative year for Ami Organics, as we proudly surpassed Rs 1,000 crore in revenue?a remarkable milestone. This achievement reflects the unwavering dedication of our employees and the invaluable support of our stakeholders, including customers, suppliers, shareholders and all other stakeholders. We extend our heartfelt gratitude for their contributions.

Looking ahead to FY26, we anticipate robust growth across all business segments, driving our confidence in achieving 25% revenue growth.?

Meanwhile, the company?s board recommended of final dividend of Rs 1.5 per equity share for FY25.

Ami Organics headquartered at Surat, is a research and development (R&D) driven manufacturer of speciality chemicals focused towards the development and manufacturing of advanced pharmaceutical intermediates for regulated and generic active pharmaceutical ingredients (APIs) and chemicals for New Chemical Entities (NCE), and other specialty chemicals.

Powered by Capital Market - Live News

Net profit of Ami Organics rose 148.43% to Rs 62.48 crore in the quarter ended March 2025 as against Rs 25.15 crore during the previous quarter ended March 2024. Sales rose 37.13% to Rs 308.48 crore in the quarter ended March 2025 as against Rs 224.96 crore during the previous quarter ended March 2024.

For the full year,net profit rose 271.08% to Rs 158.71 crore in the year ended March 2025 as against Rs 42.77 crore during the previous year ended March 2024. Sales rose 40.34% to Rs 1006.88 crore in the year ended March 2025 as against Rs 717.47 crore during the previous year ended March 2024.

Powered by Capital Market - Live News

AMI Organics announced that the Board of Directors of the Company at its meeting held on 2 May 2025, inter alia, have recommended the final dividend of Rs 1.5 per equity Share (i.e. 30%) , subject to the approval of the shareholders.

Powered by Capital Market - Live News

AMI Organics will hold a meeting of the Board of Directors of the Company on 2 May 2025.

Powered by Capital Market - Live News